Alpesib (Alpelisib) Tablets
Alpesib 150 mg (Alpelisib) is a kinase inhibitor specifically designed to target the phosphatidylinositol-3-kinase (PI3K) alpha enzyme.
Manufacturer: Everest Pharmaceuticals. Each pack contains 28 tablets. It works by inhibiting the PI3K pathway, which is often overactive in cancer cells due to mutations, specifically blocking tumor growth in patients with the PIK3CA mutation.
Precision Medicine:
Patients must be selected for treatment based on the presence of a PIK3CA mutation in tumor tissue or plasma specimens, confirmed by a validated test.
Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 13.03.2026
What Customers Say
No reviews yet
Your review can be the first!